Join Growin Stock Community!

Koninklijke philips n.v.PHG.US Overview

US StockHealthcare
(No presentation for PHG)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PHG AI Insights

PHG Overall Performance

PHG AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PHG Recent Performance

-3.80%

Koninklijke philips n.v.

0.05%

Avg of Sector

-0.31%

S&P500

PHG PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PHG Key Information

PHG Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PHG Profile

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Price of PHG

PHG FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.93
PE Ratio (TTM)
28.57
Forward PE
19.48
PS Ratio (TTM)
1.72
PB Ratio
2.37
Price-to-FCF
39.56
METRIC
VALUE
vs. INDUSTRY
Gross Margin
45.18%
Net Margin
5.02%
Revenue Growth (YoY)
-1.04%
Profit Growth (YoY)
3.67%
3-Year Revenue Growth
-2.04%
3-Year Profit Growth
1.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.93
PE Ratio (TTM)
28.57
Forward PE
19.48
PS Ratio (TTM)
1.72
PB Ratio
2.37
Price-to-FCF
39.56
Gross Margin
45.18%
Net Margin
5.02%
Revenue Growth (YoY)
-1.04%
Profit Growth (YoY)
3.67%
3-Year Revenue Growth
-2.04%
3-Year Profit Growth
1.00%

  • When is PHG's latest earnings report released?

    The most recent financial report for Koninklijke philips n.v. (PHG) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PHG's short-term business performance and financial health. For the latest updates on PHG's earnings releases, visit this page regularly.

  • Where does PHG fall in the P/E River chart?

    According to historical valuation range analysis, Koninklijke philips n.v. (PHG)'s current price-to-earnings (P/E) ratio is 14.05, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of PHG?

    According to the latest financial report, Koninklijke philips n.v. (PHG) reported an Operating Profit of 540M with an Operating Margin of 10.59% this period, representing a growth of 171.36% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PHG's revenue growth?

    In the latest financial report, Koninklijke philips n.v. (PHG) announced revenue of 5.1B, with a Year-Over-Year growth rate of 1.05%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does PHG have?

    As of the end of the reporting period, Koninklijke philips n.v. (PHG) had total debt of 8.09B, with a debt ratio of 0.3. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does PHG have?

    At the end of the period, Koninklijke philips n.v. (PHG) held Total Cash and Cash Equivalents of 2.79B, accounting for 0.1 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PHG go with three margins increasing?

    In the latest report, Koninklijke philips n.v. (PHG) achieved the “three margins increasing” benchmark, with a gross margin of 44.89%%, operating margin of 10.59%%, and net margin of 7.75%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PHG's profit trajectory and future growth potential.

  • Is PHG's EPS continuing to grow?

    According to the past four quarterly reports, Koninklijke philips n.v. (PHG)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.41. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What are the PEG ratio and PE ratio of PHG?

    The latest valuation data shows Koninklijke philips n.v. (PHG) has a Price-To-Earnings (PE) ratio of 14.05 and a Price/Earnings-To-Growth (PEG) ratio of 0.12. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.

PHG Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1